Using robotic devices to improve rehabilitation for elderly patients with Parkinson's disease

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate a new rehabilitation approach for elderly patients with Parkinson's disease by incorporating robotic devices into traditional therapy. It will involve a single-blinded randomized controlled trial with 195 participants, who will be divided into three groups: one receiving traditional rehabilitation, another using the Tymo system, and the last using Walker View alongside traditional therapy. The study will assess the effectiveness of these interventions on gait improvement and fall risk reduction, with follow-ups planned to evaluate long-term outcomes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Hoen and Yahr scale: 1-3 stage
* FAC ≤ 2
* Ranking scale score ≤ 3
* Stability of drug treatment for at least 1 month
* Geriatric Depression Scale 5-items: negative

Exclusion Criteria:

* Concomitant participation in other studies
* Lack of written informed consent
* Clinical dementia rating (CDR) score ≥ 3
* History of syncopal episodes, epilepsy and vertigo not controlled pharmacologically
* Serious dysfunction of the autonomic system
* Severe behavioral syndromes not compensated by drugs
* Concurrent neurological diseases
* Severe systemic diseases with life expectancy \< 1 year
* Patients unable to follow up.

Where it's running

• IRCCS INRCA Hospital
  Ancona, Italy Recruiting
• IRCCS INRCA Hospital
  Fermo, Italy Recruiting

Study contacts

• Study coordinator: Roberta Bevilacqua
• Email: r.bevilacqua@inrca.it
• Phone: 00390718004767

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Frailty Training for Emergency Nurses in Morocco

  This trial tests whether a four-module training program helps Moroccan emergency nurses recognize and care for frail older adults in the ER.

  Recruiting Cadi Ayyad University · Safi, SAFI · NCT07892612

• One-day exercise test to see how brain and body react in epilepsy, cognitive disorders, Parkinson's, dementia, and related conditions

  A one-day study tests how an acute bout of exercise changes brain function and bodily signals in people with certain neurological conditions compared with healthy individuals.

  Recruiting Brigham and Women's Hospital · Boston, Massachusetts · NCT07883720

• Tributyrin for PSP: a virtual, early-phase study

  This study tests whether tributyrin is safe and tolerable in people with Progressive Supranuclear Palsy who are 45 or older, using virtual visits.

  Recruiting Phase 1/2 University of Michigan · Ann Arbor, Michigan · NCT07863180

• A look at why Lewy body conditions cause visual hallucinations

  This study tests brain‑imaging in people with Lewy body diseases who do or don’t experience visual hallucinations, and in healthy volunteers, to see how brain networks might create these images.

  Recruiting NYU Langone Health · New York, New York · NCT07849413

• Zanubrutinib plus Lenalidomide for frail elderly with newly diagnosed PCNSL

  This study tests whether a combination of zanubrutinib and lenalidomide can help frail elderly patients with newly diagnosed primary CNS lymphoma.

  Recruiting Phase 2 Beijing Tiantan Hospital · Beijing, Beijing Municipality · NCT07839247

• How physical activity might help people with Parkinson’s disease who have DBS-STN implants

  This study tests whether adding regular physical activity can help people with Parkinson’s who have DBS-STN stimulation by trying a structured physiotherapy approach alongside standard care.

  Recruiting Medical University of Warsaw · Warsaw · NCT07838636

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.